EDETEK Launches CONFORM™ Statistical Computing Environment (SCE)
CONFORM SCE Delivers a new generation GXP-compliant analytical product with unlimited scalability, real-time data refresh and support for popular statistical systems to accelerate drug development
CONFORM™ Statistical Computing Environment (SCE) was built to solve many challenges faced by clinical programmers and statisticians. SCE features a cloud-native design, modern Web-based user interface, ability to support multiple programming languages, configurable Systems Development Life Cycle (SDLC) workflow, built-in version control, reproducibility of analytical results, global and secure access, and scalable computing power for interactive and scheduled jobs for clinical studies and program-based analytics.
"CONFORM™ SCE enables clinical programmers to maximize the power of the CONFORM™ Informatics Platform. SCE accelerates clinical study reporting, submission, analysis and statistical modeling while having access to fully integrated CONFORM™ modules for real time data ingestion from 70+ popular clinical and medical systems. It delivers custom configurable workflows, metadata and events management, clinical data lake and powerful designers for data validation, CDISC SDTM, ADaM mapping and transformation and TLF deliverables," said
"With the release of the CONFORM™ SCE and its analytical engine we have provided clinical analysts and scientists with the freedom to use their programming language of choice against the same data repository and models they already explore with our data visualization and scientific data assessment tools of CONFORM™ IQ," he added.
CONFORM™ SCE offers a fully GxP–compliant development environment. The platform not only provides regulatory compliance functions and controls, but also manages tasks through an intuitive integrated development environment, enhancing the efficiency of clinical programmers' daily tasks.
CONFORM™ SCE integration with any CONFORM's data pipelines and workflows enables configurations with immediate data and output refresh regardless of study size, complexity, and the number of clinical data providers. SCE can also send its output to external parties automatically upon completion of the jobs making the entire process seamless to study collaborators.
EDETEK's CONFORM™ platform has emerged as a transformative business and technical solution for increasingly complex clinical trials. It creates an end-to-end digital interoperable ecosystem to rapidly orchestrate the movement, evaluation, and submission of clinical research data through a seamless and transparent experience for all stakeholders.
About EDETEK
Founded in 2009, EDETEK is an innovative clinical solutions company that provides high-quality technology platforms and related clinical services to pharmaceutical, biotechnology, and medical device companies. Employing over 470 professionals across four continents, EDETEK's commitment to excellence remains unwavering as it collaborates with over 100 biopharmaceutical companies.
Learn more at http://www.edetek.com or reach out to [email protected].
Media Contact:
JFK Communications, Inc.
908-227-4714
[email protected]
View original content:https://www.prnewswire.com/news-releases/edetek-launches-conform-statistical-computing-environment-sce-302007765.html
SOURCE EDETEK, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuix Takes to Sibos 2026 to help Financial Institutions Turn Complex Data into Financial Crime Intelligence
- Tissue Heart Valves Market to Reach USD 25,307.93 Million by 2034, Driven by Rising Valvular Heart Disease Cases, TAVR Expansion, and Technological Advancements
- Amyotrophic Lateral Sclerosis Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2036 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share